Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-15-014662)

Filing Details

Accession Number:: 0001209191-15-014662
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-02-17 17:40:08
Reporting Period:: 2015-02-09

Filing Date:: 2015-02-17
Accepted Time:: 2015-02-17 17:40:08
Original Submission Date:: 2015-02-11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1454189	Auspex Pharmaceuticals Inc.	ASPX	Pharmaceutical Preparations (2834)	954862842

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1405712	Cmea Ventures Vii Lp	One Letterman Drive Building C, Suite Cm500 San Francisco CA 94129		No	No	Yes	No
1405972	Cmea Ventures Vii (Parallel) Lp	One Letterman Drive Building C, Suite Cm500 San Francisco CA 94129		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2015-02-10	20,670	$60.05	3,136,893	No	4	S	Direct
Common Stock	Disposition	2015-02-11	51,773	$61.84	3,085,120	No	4	S	Direct
Common Stock	Disposition	2015-02-11	1,327	$61.84	79,157	No	4	S	Indirect	By: CMEA Ventures VII (Parallel) LP

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Indirect	By: CMEA Ventures VII (Parallel) LP

Footnotes

Amendment filed on 2/17/15 to correct Amount of Securities Beneficially Owned Following Reported Transaction.